Scinai Immunotherapeutics
SCNI · NASDAQ
$0.6813−$0.0687 (−9.16%)TodayMarket closed ·
Prev close $0.75
Who owns SCNI
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 0.0% of SCNI’s shares.
- RK Stone Miami, LLC0.0%
- LCK JNK 1 LLC0.0%
- Stone (Daniel E)0.0%
- Citadel Advisors LLC0.0%
- Next 6 largest institutions0.0%
- All other shareholders100.0%
| Holder | Shares | % of shares |
|---|---|---|
| RK Stone Miami, LLC | 35.70K | 0.00% |
| LCK JNK 1 LLC | 31.74K | 0.00% |
| Stone (Daniel E) | 10.70K | 0.00% |
| Citadel Advisors LLC | 6.23K | 0.00% |
| Armistice Capital LLC | 3.59K | 0.00% |
| Sabby Management, LLC | 2.90K | 0.00% |
| Abalone Asset Management Ltd. | 2.57K | 0.00% |
| Reichman (Amir) | 1.95K | 0.00% |
| Virtu Americas LLC | 1.95K | 0.00% |
| XTX Markets LLC | 1.68K | 0.00% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Olympian SICAV - Global Equity | 2.57K | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of SCNI in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Reichman Amir | Award | 400.00M | — |
| GERMAIN MARK | Award | 120.00M | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 19.90K
- Days to cover
- 1.00
- % of shares outstanding
- 0.00%
- Average daily volume
- 1.64M
- Change since last report
- −95.6%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.